Browse: Companies | People | Financial Organizations

Home > Companies > Eiger BioPharmaceuticals

General Information
edit

Website	eigerbio.com
Category	BioTech
Email
Employees
Description	Hepatitis treatments

Offices
edit

Funding
edit

Series A, 2/09
InterWest Partners
Vivo Ventures

$7.1M

Tags
edit

Eiger BioPharmaceuticals
edit

Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.

Milestones
edit

Eiger BioPharmaceuticals received $7.1M in Series A funding. (2/25/09)

Posted 4/14/09 at 3:53am

Videos

Screenshots
edit

Sources

Eiger snaps up $7.1M to treat hepatitis (venturebeat.com) [edit]

Edit This Page
Last Edited 7/2/09

Revision History

External Links

edit

Embed Widget

CrunchBase API

JSON Representation of this page.
More API docs »

Sponsors

Become a Sponsor

Terms of Service | Privacy Policy | Licensing Policy